Search

everythinglearnresearchcommunity

for

Search:↓

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

A 45-year-old woman with autoimmune diseases experienced patchy hair loss due to alopecia areata, which has no cure but can be treated, with varying success.

A cat had a rare skin disorder with hair loss and scaling, linked to a suspected tumor.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Stress-related substance P may lead to hair loss and negatively affect hair growth.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Apoptosis is crucial for healthy skin and treating skin diseases.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Using neurohormones to control keratin can lead to new skin disease treatments.

Some skin disorders might be linked to H. pylori infection, but more research is needed to confirm this.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.